Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156295 | SCV000206013 | uncertain significance | not specified | 2017-12-26 | criteria provided, single submitter | clinical testing | The p.Val554Ile variant in CDH23 has been identified by our laboratory in 1 indi vidual with sensorineural hearing loss in a heterozygous state. This variant has been identified in 1/28330 South Asian chromosomes by the Genome Aggregation Da tabase (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs727504910). Although t his variant has been seen in the general population, its frequency is not high e nough to rule out a pathogenic role. Computational prediction tools and conserva tion analysis do not provide strong support for or against an impact to the prot ein. In summary, the clinical significance of the p.Val554Ile variant is uncerta in. ACMG/AMP Criteria applied: PM2. |
Natera, |
RCV001826850 | SCV002093622 | uncertain significance | Usher syndrome type 1 | 2019-10-28 | no assertion criteria provided | clinical testing |